01 June 2006     Reuters Press Release on Clinical Trial     A clinical trial reported in Headache indicates that daily doses of antioxidants may reduce the frequency and severity of migraine headaches.

11 December 2007     Press Release--Migco Secures First Round Funding     Press Release Migco secures funding from experienced angel investor group Movac Ltd.

08 December 2008     Migco to Present at BioPartnering N. America     Press Release--Migco to Present at BioPartnering North America 8-10 February 2009, Vancouver Canada

26 October 2009     The New Zealand Venture Investment Fund (NZVIF) joins Movac Ltd. in new funding round for Migco Pharmaceticals Ltd.     [Rangiora, New Zealand] – [26 October 2009]--Migco Pharmaceuticals announced today that has raised NZ$560,000 to continue developing its migraine prevention drug, codenamed MGX-008.

30 October 2009     Results of Migraine Clinical Trial Presented at 19th World Congress of Neurology     [Rangiora, New Zealand] – [30 October 2009]—Results were presented today to the 19th World Congress of Neurology in Bangkok, Thailand indicating positive results with Migco’s MGX 008 amongst a group of migraine patients refractory to current pharmacologic treatments.

23 November 2009     Migco Pharmaceuticals appoints new CEO     [Rangiora, New Zealand] – [23 November 2009]—Migco Pharmaceuticals Ltd announced today the appointment of Elizabeth Hopkins as CEO.